GUIDES
Which Offers We Recommend for Your First Test — and Why

Which Offers We Recommend for Your First Test — and Why

When a new advertiser joins the marketplace, they usually arrive with a perfectly understandable desire: start with the most profitable one. Putting the offer that delivers maximum profit per confirmed order into the first test seems rational — why waste time on something average when you can validate the most lucrative one right away? We hear this request regularly, and we almost always suggest the opposite: the first test should run on safe niches. In our practice, that’s diabetes and joints. And this choice has a strict rationale behind it, not just habit.

A first test is not about money. It’s about answering the question of whether we can work together at all: how the advertiser processes leads, how they get orders approved, how they give feedback. The test must produce a clean, unambiguous answer. And for that, the niche has to allow that answer to be obtained.

Why diabetes and joints

We call these niches safe not because they’re “easy,” but because the interpretation of results in them is predictable. The marketplace has accumulated market statistics for them: working approval ranges are known, buyer behavior is understood, and it’s clear what a normal test looks like versus a problematic one. When partners run traffic to such an offer and approval comes out low, the picture reads unambiguously: you can break down at which stage orders are being lost and understand where the problem lies — in the traffic, in the creatives, or in call-center processing.

The second property of a safe niche is that it reveals the advertiser’s real level. For us, the first test is essentially an operations audit: how fast the call center dials leads, how it handles objections, what share of orders gets confirmed, and how adequately the advertiser responds to feedback. In a predictable niche, all these parameters are measured cleanly, without interference from capricious demand. If the advertiser is strong — it’s visible. If they’re weak — that’s visible too, along with exactly where the weakness is.

Why not potency and similar niches

Potency and a number of similar niches are unpredictable. In them, approval depends much more heavily on factors that are poorly controlled and poorly measured: how the buyer perceives the product, the audience’s sensitivity to the pitch, script specifics, the psychological nuances of order confirmation. In a first test, this creates a fundamental interpretation problem.

Imagine: the test is launched, and approval comes out low. The question: who’s at fault? Did the call center perform poorly? Was the traffic untargeted? Did the creatives promise the wrong thing? In an unpredictable niche, separating one factor from another is nearly impossible — there are too many of them, and they’re tangled together. Such a test proves nothing: you don’t understand whether the partnership with the marketplace is working, we don’t understand what kind of advertiser you really are, and partners end up with a burned budget and no desire to return to your offers. Time and money are spent, and conclusions — zero.

That’s exactly why we don’t take potency and similar niches for a first test. Not because we “don’t work with them at all,” but because a test whose result can’t be interpreted is worse than no test at all.

What happens when the first test succeeds

A successful test on a safe niche opens the road to everything else. The scheme works like this: first we confirm that the mechanics work — leads are accepted, the call center approves at market level, feedback comes in regularly. After that, niches are added gradually, including the more complex ones. By that point, both sides already have a shared history: we know your real processing level, you know what kind of traffic our partners deliver, and new niches are launched not blindly but on a proven foundation.

Volume matters here too. We start the first test with a limited number of leads — usually 50–100 per day, depending on your capabilities. We discuss cap potential in advance: how much the volume can grow if the test goes well. This is also part of the answer to “can we work together” — it’s more interesting to work with advertisers who are ready to scale.

The principle we follow

Let’s state it plainly: the first test must answer the question “can we work together,” not the question “which niche is the most profitable.” These two questions almost always lead to different choices, and you need to choose the first one.

Niche profitability matters over the long run — but the long run begins only after the essentials are proven: the advertiser accepts traffic, processes it well, confirms orders at market level, and is plugged into a format of constant feedback. To that end, we ask the advertiser to inform us about incorrect creatives, mistakes and nuances on the partners’ side, about incorrect volumes — and we ourselves watch how this communication takes shape over the course of the test. Not every advertiser already works this way, but it’s the standard we’re moving toward.

Before the test, a few formal but mandatory steps remain. We need statistics for at least a week, and preferably 2–3 months: organic approval, volumes, dynamics. Without statistics we don’t connect — a blind test contradicts the very idea of a clean validation. After agreeing on terms, we sign the contract and fill in the offer information. A deposit is required to start working.

Conclusion

If you’re offered to start with diabetes or joints instead of your most profitable offer — that’s not an attempt to lowball the test. It’s a way to make the test honest: to get a result on which both sides can make a decision, rather than a set of numbers everyone interprets however they like. A safe niche will show your real level, and success in it will open up the rest — gradually and on clear terms.

Ready to discuss your first test? Send us your offer statistics — we’ll pick the niche and terms for launch.

You may also like